| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/19/2007 | CA2625976A1 Method and means for determining the replication rate of a viral population |
| 04/19/2007 | CA2625744A1 Diabetes-associated markers and methods of use thereof |
| 04/19/2007 | CA2625681A1 Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38 |
| 04/19/2007 | CA2625649A1 Method of tacrolimus extraction and quantification using aqueous detergents |
| 04/19/2007 | CA2625349A1 Methods and compositions relating to anthrax spore glycoproteins as vaccines |
| 04/19/2007 | CA2625291A1 Egfr dependent modulation of chemokine expression and influence on therapy and diagnosis of tumors and side effects thereof |
| 04/19/2007 | CA2625072A1 Sequences for detection and identification of methicillin-resistant staphylococcus aureus (mrsa) of mrej types xi to xx |
| 04/19/2007 | CA2624781A1 Nanobodies tm and polypeptides against egfr and igf-ir |
| 04/19/2007 | CA2624581A1 Non-invasive in vitro method to detect transitional cell carcinoma of the bladder |
| 04/19/2007 | CA2624559A1 Optimal polyvalent vaccine for cancer |
| 04/19/2007 | CA2624370A1 Method for a rapid test of the quality of grains, crushed grains, and flours, by means of measuring the gluten aggregation |
| 04/19/2007 | CA2624280A1 Device for the analysis of liquid samples |
| 04/19/2007 | CA2609116A1 Animal model of schizophrenia |
| 04/18/2007 | EP1775592A1 Analyzer, method for specifying reaction vessel in analyzer, and analytical apparatus |
| 04/18/2007 | EP1775590A1 Non-invasive in vitro method to detect transitional cell carcinoma of the bladder |
| 04/18/2007 | EP1775589A1 Dna chip manufacturing method, manufacturing system, hybridization detection method, detection system, substrate treatment device, and substrate treatment method |
| 04/18/2007 | EP1775588A1 Method for detecting the effect of a toxic substance using sub-mitochondrial particle |
| 04/18/2007 | EP1775586A1 Method for electrophysiological investigation of a membran having an ion channel |
| 04/18/2007 | EP1775585A1 Medical image processing system |
| 04/18/2007 | EP1775584A2 Method for detecting the quality of fuel for internal combustion engines |
| 04/18/2007 | EP1775581A1 Examination of amino acid sequence constituting peptide depending on isotopic ratio |
| 04/18/2007 | EP1775577A1 Portable, scanning and analyzing apparatus |
| 04/18/2007 | EP1775574A1 Method of auto-discrimination of test sample |
| 04/18/2007 | EP1775360A2 Method and apparatus for calculating winding diameter in textile machine |
| 04/18/2007 | EP1775000A2 Method of producing universal blood plasma from blood |
| 04/18/2007 | EP1774356A1 Process for the determination of lipoproteins in body fluids |
| 04/18/2007 | EP1774340A1 Insulin promoter factor 1 as target/marker of beta cell failure |
| 04/18/2007 | EP1774339A2 Pancreatic polypeptide as target/marker of beta cell failure |
| 04/18/2007 | EP1774338A1 Timp-2 as target/marker of beta cell failure |
| 04/18/2007 | EP1774337A1 Protein differentiation |
| 04/18/2007 | EP1774336A1 Method and kit for determining the immunisation status of a person |
| 04/18/2007 | EP1774335A1 Magnetic particle capture of whole intact organisms from clinical samples |
| 04/18/2007 | EP1774334A2 Use of magnetic material to direct isolation of compounds and fractionation of multipart samples |
| 04/18/2007 | EP1774333A1 Testing method of analytic chip of multiple reactors, the analytic chip, and the testing device |
| 04/18/2007 | EP1774332A2 Immune response assessment method |
| 04/18/2007 | EP1774331A2 Cytoxan antibodies and immunoassay |
| 04/18/2007 | EP1774330A2 Methods for the detection of molecular interactions within cells |
| 04/18/2007 | EP1774329A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 04/18/2007 | EP1774328A1 Biomarkers for rheumatoid arthritis (ra) |
| 04/18/2007 | EP1774327A2 Methods and kits for measuring adamts13/fxi complexes |
| 04/18/2007 | EP1774326A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a) |
| 04/18/2007 | EP1774325A2 Methods for identifying stem cells based on nuclear morphotypes |
| 04/18/2007 | EP1774324A1 Electrochemical sensor for in-vivo or ex-vivo measurements of the carbon dioxide partial pressure of living tissue |
| 04/18/2007 | EP1774323A2 Automated analysis of multiplexed probe-traget interaction patterns: pattern matching and allele identification |
| 04/18/2007 | EP1774322A2 System and method for processing results of a complex genetic test |
| 04/18/2007 | EP1774321A1 Method for determining the presence of a chemical compound which is homogeneously distributed in a medium by means of cross-correlating a measuring spectrum with reference spectra |
| 04/18/2007 | EP1774320A1 Method for predicting final saturation of an organic liquid phase in a porous medium |
| 04/18/2007 | EP1774319A1 Method for analyzing oligomeric proanthocyanidin (opc) |
| 04/18/2007 | EP1774318A2 Models and methods for nociception, pain transduction, and screening for analgesic compounds |
| 04/18/2007 | EP1774317A1 IMMUNE-COMPROMISED TRANSGENIC MICE EXPRESSING HUMAN HEPATOCYTE GROWTH FACTOR (hHGF) |
| 04/18/2007 | EP1774316A2 Phased micro analyzer |
| 04/18/2007 | EP1774313A1 Phased vii micro fluid analyzer having a modular structure |
| 04/18/2007 | EP1774303A1 Method and apparatus for electrochemical detection |
| 04/18/2007 | EP1774278A2 Monitoring system for concrete pilings and method of installation |
| 04/18/2007 | EP1774046A2 Novel nucleotide and amino acid sequences and assays and methods of use thereof for diagnosis of lung cancer |
| 04/18/2007 | EP1774044A2 Methods of screening for cell proliferation or neoplastic disorders |
| 04/18/2007 | EP1774037A2 Assays and methods using biomarkers |
| 04/18/2007 | EP1774033A2 Multiplexing assays for analyte detection |
| 04/18/2007 | EP1774028A1 Methods and compositions for treating obesity |
| 04/18/2007 | EP1774024A2 Exploring fluorophore microenvironments |
| 04/18/2007 | EP1774022A1 Methods and compositions for modulating hepatocyte growth factor activation |
| 04/18/2007 | EP1774020A2 Phage microarray profiling of the humoral response to disease |
| 04/18/2007 | EP1774019A2 Look-through mutagenesis for developing altered polypeptides with enhanced properties |
| 04/18/2007 | EP1774018A2 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination |
| 04/18/2007 | EP1773997A2 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases |
| 04/18/2007 | EP1773990A2 Capsules containing transfected cells, method for preparing the same and use thereof for immunization and vaccination |
| 04/18/2007 | EP1773989A2 Method of screening candidate compounds for susceptibility to biliary excretion |
| 04/18/2007 | EP1773886A1 Improved method of selecting a desired protein from a library |
| 04/18/2007 | EP1773883A2 Antibodies against cancer produced using masked cancer cells as immunogen |
| 04/18/2007 | EP1773882A2 Diagnosis and treatment of siglec-6 associated diseases |
| 04/18/2007 | EP1773876A1 Hpv vaccine comprising peptides from host cell proteins |
| 04/18/2007 | EP1773873A2 Novel polypeptides for isolating in vitro and preventing staphyloccocal infections on joint prostheses and other implanted foreign materials |
| 04/18/2007 | EP1773872A2 Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof |
| 04/18/2007 | EP1773871A2 Tdf-related compounds and analogs thereof |
| 04/18/2007 | EP1773866A1 Use of metal complexes |
| 04/18/2007 | EP1773762A2 Methods and compounds for detection of medical disorders |
| 04/18/2007 | EP1773699A2 Napkin dispenser |
| 04/18/2007 | EP1773406A2 Method for screening agents against human prostate disease |
| 04/18/2007 | EP1773392A2 Method for preventing and treating mast cell mediated diseases |
| 04/18/2007 | EP1773305A2 Method for treating skeletal disorders resulting from fgfr malfunction |
| 04/18/2007 | EP1700103A4 Conducting polymer nanofiber sensors |
| 04/18/2007 | EP1685367A4 Fiber-optic assay apparatus based on phase-shift interferometry |
| 04/18/2007 | EP1678318A4 Detection of potassium ions using ion-sensitive enzymes |
| 04/18/2007 | EP1613734A4 Visualizing expression data on chromosomal graphic schemes |
| 04/18/2007 | EP1611250A4 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer |
| 04/18/2007 | EP1567862A4 Compositions and methods for the reversible capture of biomolecules |
| 04/18/2007 | EP1567677A4 Detection of protease enzymes |
| 04/18/2007 | EP1527098A4 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| 04/18/2007 | EP1514115B1 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof |
| 04/18/2007 | EP1470156B1 Polymorphisms of the octn1 and octn2 cation transporters associated with inflammatory bowel disease |
| 04/18/2007 | EP1428835B1 Antibody against metastin and use of the same in the diagnosis of pregnancy |
| 04/18/2007 | EP1423706B1 Determination and quantification of red blood cell populations in samples |
| 04/18/2007 | EP1395657B1 Receptor for bacillus anthracis toxin |
| 04/18/2007 | EP1379266B1 Modified annexin proteins and prevention and treatment of thrombosis |
| 04/18/2007 | EP1352063B1 Receptor nucleic acids and polypeptides |
| 04/18/2007 | EP1349569B1 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof |
| 04/18/2007 | EP1347300B1 Method of measuring binding activity of ligand-binding protein having poor chemical stability to first ligand |
| 04/18/2007 | EP1335976B1 Modifier of organelle metalbolism |
| 04/18/2007 | EP1334194B1 Imaging, diagnosis and treatment of disease |
| 04/18/2007 | EP1324652B1 Transgenic drosophila melanogaster expressing beta amyloid |